Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
UNH UnitedHealth
- 520.480
- +4.720+0.92%
Close Dec 13 16:00 ET
- 521.965
- +1.485+0.29%
Post 20:01 ET
478.99BMarket Cap33.84P/E (TTM)
527.530High510.720Low8.20MVolume515.640Open515.760Pre Close4.27BTurnover0.89%Turnover Ratio21.81P/E (Static)920.28MShares628.31452wk High5.07P/B477.68BFloat Cap431.33552wk Low7.96Dividend TTM917.78MShs Float628.314Historical High1.53%Div YieldTTM3.26%Amplitude2.933Historical Low520.381Avg Price1Lot Size
UnitedHealth Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 102.04%13.95B | -38.85%6.75B | -92.99%1.14B | 10.92%29.07B | -14.56%-5.19B | -62.79%6.9B | 60.56%11.03B | 206.96%16.33B | 17.29%26.21B | -240.86%-4.53B |
| Net income from continuing operations | 3.64%6.26B | -21.85%4.42B | -121.15%-1.22B | 12.14%23.14B | 15.63%5.68B | 12.15%6.04B | 8.81%5.66B | 12.16%5.77B | 16.39%20.64B | 17.11%4.91B |
| Operating gains losses | --20M | --1.23B | --7.09B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 3.38%1.04B | -0.10%1.02B | 2.78%997M | 16.82%3.97B | -0.81%974M | 21.62%1.01B | 27.31%1.02B | 23.10%970M | 9.57%3.4B | 27.37%982M |
| Deferred tax | 1,133.33%124M | -120.67%-331M | 91.87%-27M | 63.60%-245M | 400.00%249M | 97.91%-12M | 14.77%-150M | -306.21%-332M | -617.69%-673M | 65.84%-83M |
| Other non cash items | -3,440.63%-1.07B | 275.00%280M | 159.42%179M | -52.57%-505M | ---446M | --32M | -180.81%-160M | 305.88%69M | 64.94%-331M | ---- |
| Change In working capital | 1,888.78%7.33B | -102.06%-91M | -165.82%-6.24B | -26.85%1.64B | -15.54%-11.85B | -103.16%-410M | 587.71%4.42B | 966.91%9.48B | 47.57%2.25B | -967.53%-10.26B |
| -Change in receivables | 213.89%3.16B | -18.03%3.69B | -43.10%-6.16B | -23.42%-3.11B | -1,450.00%-540M | -268.86%-2.77B | 1,320.50%4.5B | 4.76%-4.31B | -152.30%-2.52B | 126.14%40M |
| -Change in payables and accrued expense | 18.65%2.67B | -232.79%-1.03B | -56.88%1.84B | 16.30%7B | 93.40%791M | 191.71%2.25B | -177.39%-308M | -3.94%4.26B | 55.76%6.02B | 133.17%409M |
| -Change in other current assets | ---- | ---- | -2.77%-1.93B | -77.87%-2.44B | ---- | ---- | ---- | ---1.88B | -33.27%-1.37B | ---- |
| -Change in other current liabilities | 417.37%1.13B | ---- | ---- | ---- | ---- | -264.29%-357M | ---- | ---- | ---- | ---- |
| -Change in other working capital | -19.96%373M | -259.49%-563M | -99.92%9M | 61.11%203M | -19.29%-12.02B | -95.62%466M | 168.15%353M | 14,517.95%11.4B | 140.65%126M | -48,076.19%-10.08B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 102.04%13.95B | -38.85%6.75B | -92.99%1.14B | 10.92%29.07B | -14.56%-5.19B | -62.79%6.9B | 60.56%11.03B | 206.96%16.33B | 17.29%26.21B | -240.86%-4.53B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -114.13%-5.65B | -918.82%-7.42B | 42.47%-6.34B | 45.31%-15.57B | 92.28%-1.19B | -211.57%-2.64B | 91.52%-728M | -200.03%-11.02B | -174.55%-28.48B | -2,246.51%-15.37B |
| Net PPE purchase and sale | -18.26%-991M | -2.90%-853M | 2.24%-743M | -20.84%-3.39B | -10.74%-959M | -15.75%-838M | -26.18%-829M | -36.94%-760M | -14.18%-2.8B | -24.60%-866M |
| Net business purchase and sale | -3,690.79%-8.64B | 92.54%-25M | 61.59%-3.01B | 52.76%-10.14B | 87.79%-1.75B | -5,600.00%-228M | 94.34%-335M | -535.74%-7.83B | -345.09%-21.46B | -15,117.02%-14.3B |
| Net investment purchase and sale | 262.46%2.07B | -195.70%-713M | 121.22%492M | 74.01%-1.78B | 138.74%1.07B | -82.03%-1.28B | 142.96%745M | -42.10%-2.32B | -270.97%-6.84B | -249.00%-2.77B |
| Net other investing changes | 743.10%1.91B | -1,785.44%-5.83B | -2,580.87%-3.08B | -110.49%-275M | -82.65%446M | -151.03%-297M | -11.55%-309M | 54.90%-115M | 309.01%2.62B | 826.27%2.57B |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -114.13%-5.65B | -918.82%-7.42B | 42.47%-6.34B | 45.31%-15.57B | 92.28%-1.19B | -211.57%-2.64B | 91.52%-728M | -200.03%-11.02B | -174.55%-28.48B | -2,246.51%-15.37B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 68.96%-2.21B | 88.56%-1.2B | -37.60%8.23B | -372.81%-11.53B | -262.93%-7.16B | -107.96%-7.1B | -1,205.60%-10.46B | 472.48%13.19B | 156.69%4.23B | 221.09%4.39B |
| Net issuance payments of debt | 226.15%2.33B | 130.47%1.43B | -8.17%11.36B | -65.86%4.28B | -117.96%-1.57B | 21.60%-1.85B | -213.76%-4.68B | 504.25%12.38B | 405.28%12.54B | 797.28%8.73B |
| Net common stock issuance | 91.83%-89M | 109.50%258M | -56.16%-2.59B | -15.66%-6.65B | -42.72%-1.19B | -62.05%-1.09B | -18.34%-2.72B | 15.03%-1.66B | -57.67%-5.75B | -7.64%-831M |
| Cash dividends paid | -11.39%-1.94B | -10.76%-1.94B | -12.49%-1.73B | -12.85%-6.76B | -12.78%-1.74B | -12.78%-1.74B | -13.07%-1.75B | -12.77%-1.54B | -13.47%-5.99B | -12.89%-1.54B |
| Net other financing activities | -3.29%-2.51B | 28.19%-945M | -70.51%1.18B | -170.04%-2.4B | -35.50%-2.66B | -310.49%-2.43B | -295.83%-1.32B | 12.33%4.01B | 439.07%3.43B | -726.05%-1.97B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 68.96%-2.21B | 88.56%-1.2B | -37.60%8.23B | -372.81%-11.53B | -262.93%-7.16B | -107.96%-7.1B | -1,205.60%-10.46B | 472.48%13.19B | 156.69%4.23B | 221.09%4.39B |
| Net cash flow | ||||||||||
| Beginning cash position | -37.13%26.29B | -32.21%28.41B | 8.83%25.43B | 9.31%23.37B | 0.18%38.92B | 69.89%41.81B | 64.48%41.91B | 9.31%23.37B | 26.32%21.38B | 84.23%38.85B |
| Current changes in cash | 314.33%6.09B | -1,104.52%-1.87B | -83.59%3.04B | 0.46%1.97B | 12.73%-13.54B | -119.89%-2.84B | 79.87%-155M | 368.28%18.5B | -56.69%1.96B | -5,152.12%-15.51B |
| Effect of exchange rate changes | 124.56%14M | -92.73%4M | -194.12%-48M | 185.29%97M | 60.00%48M | -7.55%-57M | 155.00%55M | -67.52%51M | 154.84%34M | 276.47%30M |
| End cash Position | -16.74%32.4B | -37.13%26.29B | -32.21%28.41B | 8.83%25.43B | 8.83%25.43B | 0.18%38.92B | 69.89%41.81B | 64.48%41.91B | 9.31%23.37B | 9.31%23.37B |
| Free cash flow | 113.62%12.95B | -42.24%5.89B | -97.42%401M | 9.73%25.68B | -13.95%-6.15B | -65.98%6.06B | 64.19%10.2B | 226.76%15.57B | 17.67%23.4B | -313.99%-5.4B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.